Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Dimesna

Copy Product Info
😃Good
Catalog No. T1672Cas No. 16208-51-8
Alias BNP-7787

Dimesna (BNP-7787) is a synthetic derivative of dithio-ethane sulfonate with uroprotective properties.

Dimesna

Dimesna

Copy Product Info
😃Good
Purity: 99.90%
Catalog No. T1672Alias BNP-7787Cas No. 16208-51-8
Dimesna (BNP-7787) is a synthetic derivative of dithio-ethane sulfonate with uroprotective properties.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
100 mg$34In StockIn Stock
500 mg$107In StockIn Stock
1 g$157-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.90%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Dimesna AI Summary
Dimesna exhibits bioactivity as an inhibitor of Plasmodium falciparum proliferation with varying potencies against different strains: 0.9 nM against the 3D7 strain, 298.3 nM against the DD2 strain, 14950.2 nM against the DD2 strain in repeat assays, and 1.7 nM against the HB3 strain. Additionally, Dimesna displays potential antiviral activity against SARS-CoV-2. It inhibits SARS-CoV-2 induced cytotoxicity in Caco-2 cells by 0.13% at a concentration of 10 µM after 48 hours and shows 14.1% inhibition of the SARS-CoV-2 3CL-Pro protease at 20 µM. Another assay indicated minimal inhibition (-0.1%) of SARS-CoV-2 cytotoxicity in Vero-6 cells at 10 µM after 48 hours. This suggests limited but observable antiviral properties, particularly targeting the protease activity of SARS-CoV-2..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Dimesna (BNP-7787) is a synthetic derivative of dithio-ethane sulfonate with uroprotective properties.
In vitro
Dimesna modulated paclitaxel-induced MTP hyperpolymerization, and mesna, an in vivo metabolite of Dimesna, prevented cisplatin-induced MTP inactivation. The renal organic anion transporter proteins OAT1 (KM=636 μM), OAT3 (KM=390 μM) and OAT4 (KM=590 μM) were able to specifically bind Dimesna.
In vivo
Dimesna modulated paclitaxel-induced MTP hyperpolymerization, and mesna, an in vivo metabolite of Dimesna, prevented cisplatin-induced MTP inactivation. The renal organic anion transporter proteins OAT1 (KM=636 μM), OAT3 (KM=390 μM) and OAT4 (KM=590 μM) were able to specifically bind Dimesna.
SynonymsBNP-7787
Chemical Properties
Molecular Weight326.34
FormulaC4H8Na2O6S4
Cas No.16208-51-8
Smiles[O-]S(=O)(=O)CCSSCCS(=O)(=O)[O-].[Na+].[Na+]
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 13 mg/mL (39.84 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0643 mL15.3214 mL30.6429 mL153.2144 mL
5 mM0.6129 mL3.0643 mL6.1286 mL30.6429 mL
10 mM0.3064 mL1.5321 mL3.0643 mL15.3214 mL
20 mM0.1532 mL0.7661 mL1.5321 mL7.6607 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Dimesna | purchase Dimesna | Dimesna cost | order Dimesna | Dimesna chemical structure | Dimesna in vivo | Dimesna in vitro | Dimesna formula | Dimesna molecular weight